Asahi Kasei Pharma Corp. - Product Pipeline Review - 2014 - Market Size, Share, Growth

Description

Global Markets Directs, Asahi Kasei Pharma Corp. Product Pipeline Review 2014, provides an overview of the Asahi Kasei Pharma Corp.s pharmaceutical research and development focus.

View Full Report At: http://www.marketresearchreports.biz/analysis/234491

This report provides comprehensive information on the current therapeutic developmental pipeline of Asahi Kasei Pharma Corp.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Download Sample Of This Report: http://www.marketresearchreports.biz/sample/sample/234491

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope

The report provides brief overview of Asahi Kasei Pharma Corp. including business description, key information and facts, and its locations and subsidiariesThe report reviews current pipeline of Asahi Kasei Pharma Corp.s human therapeutic division and enlists all their major and minor projectsThe report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones Special feature on out-licensed and partnered product portfolioThe report summarizes all the dormant and discontinued pipeline projectsLatest company statement Latest news and deals relating to the Asahi Kasei Pharma Corp.s pipeline products

Related Reports

TaiGen Biotechnology Co., Ltd. - Product Pipeline Review - 2014

View Full Report at: http://www.marketresearchreports.biz/analysis/223408

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites.

Download Sample Of This Report: http://www.marketresearchreports.biz/sample/sample/223408

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Zosano, Inc. - Product Pipeline Review - 2014

View Full Report at: http://www.marketresearchreports.biz/analysis/223409

This report provides comprehensive information on the current therapeutic developmental pipeline of Zosano Pharma, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

Download Sample Of This Report: http://www.marketresearchreports.biz/sample/sample/223409

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.